Fairfield Financial Advisors, LTD Astrazeneca PLC Transaction History
Fairfield Financial Advisors, LTD
- $284 Billion
- Q4 2024
A detailed history of Fairfield Financial Advisors, LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 2,242 shares of AZN stock, worth $173,979. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,242
Previous 2,832
20.83%
Holding current value
$173,979
Previous $221 Million
33.43%
% of portfolio
0.05%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,367Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.68 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.18 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.91 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.87 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.86 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...